Novavax (NVAX) Receivables - Other (2011 - 2026)
Novavax (NVAX) posted quarterly Receivables - Other of $4.2 million for Q1 2026, down 31.15% year-over-year from $6.1 million in Q1 2025, and down 61.11% quarter-over-quarter from $10.8 million in Q4 2025.
Novavax (NVAX) Receivables - Other (2011 - 2026) Analysis & Trends
Novavax's Receivables - Other history runs 13 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- In Q1 2026, Receivables - Other fell 31.15% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $4.2 million (down 31.15% YoY), while the FY2025 annual figure was $10.8 million, up 100.0% from the prior year.
- Receivables - Other for Q1 2026 stood at $4.2 million, down from $10.8 million in the prior quarter.
- The five-year high for Receivables - Other was $68.0 million in Q3 2022, with the low at $200000.0 in Q1 2024.
- The 5-year median for Receivables - Other is $10.8 million (2023), against an average of $23.0 million.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other sank 99.53% in 2024, then jumped 2950.0% in 2025.
- Novavax's Receivables - Other stood at $28.6 million in 2022, then sank by 62.24% to $10.8 million in 2023, then slumped by 50.0% to $5.4 million in 2024, then surged by 100.0% to $10.8 million in 2025, then sank by 61.11% to $4.2 million in 2026.
- Business Quant data shows NVAX's Receivables - Other at $4.2 million in Q1 2026, $10.8 million in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.10 Mn |
| Jun 30, 2026 | 4.10 Mn |
| Mar 31, 2026 | 4.20 Mn |
| Mar 31, 2026 | 4.20 Mn |
| Dec 31, 2025 | 10.80 Mn |
| Dec 31, 2025 | 10.80 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Mar 31, 2025 | 6.10 Mn |
| Mar 31, 2025 | 6.10 Mn |
| Dec 31, 2024 | 5.40 Mn |
| Dec 31, 2024 | 5.40 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 2.30 Mn |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |